الصفحة الرئيسية>>Signaling Pathways>> Tyrosine Kinase>> FGFR>>TAS-120

TAS-120 (Synonyms: TAS-120)

رقم الكتالوجGC19156

TAS-120 (TAS-120) هو مثبط FGFR متوفر بيولوجيًا عن طريق الفم ، انتقائي للغاية ، ولا رجوع فيه ، مع IC50s من 3.9 و 1.3 و 1.6 و 8.3 نانومتر لـ FGFR 1-4 ، على التوالي. TAS-120 يمنع FGFR2 المتحولة والبرية مع IC50s مماثلة (من النوع البري FGFR2 = 0.9 نانومتر ؛ V5651 = 1-3 نانومتر ؛ N550H = 3.6 نانومتر ؛ E566G = 2.4 نانومتر).

Products are for research use only. Not for human use. We do not sell to patients.

TAS-120 التركيب الكيميائي

Cas No.: 1448169-71-8

الحجم السعر المخزون الكميّة
1mg
54٫00
متوفر
5mg
135٫00
متوفر
10mg
198٫00
متوفر
25mg
378٫00
متوفر
50mg
585٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Futibatinib (TAS-120) is an orally bioavailable, highly selective, and irreversible FGFR inhibitor. Futibatinib (TAS-120) covalently binds to a highly conserved P-loop cysteine residue in the ATP pocket of FGFR. Futibatinib (TAS-120) exhibits potency at low nanomolar concentrations and high specificity against wild-type FGFR1/2/3/4 as well as against some FGFR2 kinase domain mutations[1][2].

Futibatinib (TAS-120) (3, 30, 100 mg/kg/day, p.o.) exerts an anti-tumor effect in mice. Futibatinib (TAS-120) shows anti-tumor effect by administering at moderate intervals, such as intermittent administration of every other day dosing and 2 times/week, and reducing the sustained elevation and weight suppression blood phosphorus level, and take a antitumor effective as daily administration[1].

References:
[1]. Goyal L, et al. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma. Cancer Discov. 2019 Aug;9(8):1064-1079.
[2]. Kalyukina M, et al. TAS-120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure. ChemMedChem. 2019 Feb 19;14(4):494-500.

مراجعات

Review for TAS-120

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for TAS-120

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.